Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Parkinson’s Disease – Pipeline Review, H2 2016, provides an overview of the Parkinson’s Disease (Central Nervous System) pipeline landscape.
Parkinson’s disease is a neurodegenerative disorder characterized by movement dysfunctions. It causes involuntary shaking, stiffness and impaired locomotory functions. Age, genetic factors, head trauma, environmental factors, hormonal changes, etc are predisposing factors for Parkinson’s disease. Parkinson’s disease results in abnormal functioning or death of neurons. The neurons are responsible for the synthesis of neurotransmitter dopamine which is further responsible for the transmission of signals. The effect on the neurons blocks effective neurotransmission and may lead to eventual decline in movement and coordination.
Browse the full report @ http://orbisresearch.com/reports/index/parkinsons-disease-pipeline-review-h2-2016 .
Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Parkinson’s Disease – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Parkinson’s Disease (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Parkinson’s Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Parkinson’s Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 10, 30, 37, 5, 173, 42 and 3 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical, Discovery and Unknown stages comprises 1, 1, 50, 15 and 1 molecules, respectively.
Place a direct purchase order on this report at @ http://www.orbisresearch.com/contact/purchase/165806 .
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
– The pipeline guide provides a snapshot of the global therapeutic landscape of Parkinson’s Disease (Central Nervous System).
– The pipeline guide reviews pipeline therapeutics for Parkinson’s Disease (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Parkinson’s Disease (Central Nervous System) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Parkinson’s Disease (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Parkinson’s Disease (Central Nervous System)
Request a sample Parkinson’s Disease-Pipeline Review, H2 2016
2-BBB Medicines BV
4P Therapeutics LLC
AC Immune SA
Acorda Therapeutics Inc
Adamas Pharmaceuticals Inc
Addex Therapeutics Ltd
Advinus Therapeutics Ltd
Aeolus Pharmaceuticals Inc
Amarantus Bioscience Holdings Inc
American Gene Technologies International Inc
Anavex Life Sciences Corp
Aoxing Pharmaceutical Company Inc
APeT Holding BV
Araclon Biotech SL
Arrien Pharmaceuticals LLC
AudioCure Pharma GmbH
Bial – Portela & Ca SA
Bio-Modeling Systems SAS
Biotie Therapies Corp
BrainStorm Cell Therapeutics Inc
Cantabio Pharmaceuticals Inc
Carna Biosciences Inc
Cell Cure Neurosciences Ltd
CHA Bio & Diostech Co Ltd
Chipscreen Biosciences Ltd
Clevexel Pharma SA
Contera Pharma ApS
ContraVir Pharmaceuticals Inc
Corium International Inc
Daewoong Pharmaceutical Co Ltd
Denali Therapeutics Inc
Diffusion Pharmaceuticals Inc
Dizlin Medical Design AB
Domain Therapeutics SA
Edison Pharmaceuticals Inc
Eli Lilly and Company
Ensemble Therapeutics Corp
Fabre-Kramer Pharmaceuticals Inc
FPRT Bio Inc
Generon (Shanghai) Corp Ltd
Genervon Biopharmaceuticals LLC
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: email@example.com